Tag: mathematics
-
Real-World Data Shown to Match Eye Disease Trial Results
Research findings show data in patients’ electronic health records can be collected and analyzed to replicate results from late-stage clinical trials of an eye disease biologic drug.
-
Trial to Assess At-Home Asthma Lung Function Tests
A clinical trial is set to begin that compares monitoring of lung functions in people with asthma using portable ultrasound and mobile app at home to conventional tests in a clinic.
-
Environmental Biomarker Start-Up Gains $16M in Early Funds
A new company developing diagnostics for neurological and other disorders based on environmental exposures is raising $16 million in venture funds.
-
Audio Digital Biomarkers Start-Up Raises $3.7M in Seed Funds
A new company developing techniques to analyze internal physiological sounds captured by stethoscopes as health indicators is raising $3.7 million in seed funds.
-
Project to Sequence 20K Dog and Cat Genomes
Some 20,000 dogs and cats are expected to have their genomes sequenced in the next 10 years for a publicly available database to enable precision medicine for pets.
-
BioNTech to Provide Personal Cancer Immunotherapies in UK
The biotechnology company BioNTech SE is partnering with the U.K. government to provide up to 10,000 personalized cancer immunotherapy treatments by 2030.
-
Protein Chemistry Biotech Gains Collaboration, Venture Funds
An enterprise discovering new drugs with optical light-based protein chemistry is emerging from stealth, including work with biopharmaceutical company Genentech.
-
Immune Organoid Company Raises $4.3M in Seed Funds
A new company developing 3-D cell and tissue models of lymph nodes for discovery of immunotherapies is raising $4.3 million in seed funds.
-
Brain-Computer Interface Company Raises $75M in New Funds
A developer of an implanted electronic system that captures and transmits thoughts of movement into signals for digital devices is raising $75 million in venture funds.
-
FDA Clears AI Heart Failure Detection System
The Food and Drug Administration authorized for marketing an algorithm-driven medical device for diagnosing a common, but difficult to detect, type of heart failure.